Injective (INJ) Rallies 15%: EVM Testnet Launch and Strategic Partnerships Drive Growth

Terrill Dicki
Jul 14, 2025 07:53

Injective (INJ) surged 15% this week, fueled by its EVM testnet launch, strategic partnerships with Google Cloud and Deutsche Telekom, and growing DeFi adoption.

1. Executive Summary

Injective Protocol (INJ) has experienced a bullish surge over the past week, driven by a series of impactful developments. These include the launch of its EVM testnet, strategic partnerships with tech giants Google Cloud and Deutsche Telekom, and a significant increase in on-chain activity. The platform’s focus on real-world asset (RWA) tokenization and institutional integration has positioned it as a leader in decentralized finance (DeFi). With INJ trading at $12.88, technical indicators suggest further potential upside, though market volatility remains a consideration.

---

2. Recent Market Developments

The past week has been monumental for Injective, with several key events shaping market sentiment:

• EVM Testnet Launch and Partnerships (July 13, 2025):
  Injective’s EVM testnet launch marked a significant milestone, enhancing compatibility with Ethereum-based assets. This development aligns with the platform’s push for RWA tokenization. Strategic partnerships with Google Cloud and Deutsche Telekom further validated Injective’s institutional appeal, driving a 15% price surge and boosting daily active addresses by 1,700% since January.

• Formation of the Injective Council (July 12, 2025):
  The newly established Injective Council includes leaders from top-tier organizations like BitGo, Galaxy, and NTT Digital. This move aims to accelerate institutional adoption and DeFi innovation, with INJ gaining 27% over the week, closing at $12.75 on July 12.

• Increased Whale Activity (July 12, 2025):
  Whale activity and strong volume contributed to INJ’s bullish momentum, breaking a multi-month downtrend. Analysts are now eyeing resistance levels at $14.16 and $15.43.

• Market Trends and Technical Signals (July 9, 2025):
  Despite a slight price dip earlier in the week, Injective’s fundamentals remain strong. Total Value Locked (TVL) rose by 65% since April, reflecting growing interest in its DeFi solutions.

These developments underscore Injective’s growing dominance in the DeFi space, positioning it as a key player in global blockchain adoption.

---

3. Technical Analysis

As of July 14, 2025, Injective’s technical indicators reveal a weak bullish trend with potential for further gains:

• Current Price: $12.88
• 24h Change: +1.90%
• Resistance Levels: $13.16, $15.48
• Support Levels: $10.07, $8.95

Moving Averages:
– SMA7: $11.92
– SMA20: $11.22
– SMA50: $11.83
– SMA200: $13.23

The price trading above short-term moving averages indicates bullish momentum. However, the 200-day SMA serves as a critical resistance point.

Momentum Indicators:
– RSI (14): 62.30 (approaching overbought territory)
– MACD Histogram: 0.2726 (bullish crossover)
– Stochastic Oscillator: %K at 90.94, signaling overbought conditions

Bollinger Bands:
– Upper: $12.76
– Lower: $9.68
– %B: 1.0376 (indicating strong upward pressure)

The technical outlook suggests cautious optimism, with a focus on breaking the $13.16 resistance.

---

4. Trading Strategy and Signals

Short-Term Strategy:
– Consider entering long positions if INJ consolidates above $13.16, targeting $14.16 and $15.43.
– Monitor RSI and Stochastic levels for signs of overbought conditions to avoid potential pullbacks.

Stop-Loss Recommendation:
– Place stop-loss orders below $10.07 to mitigate downside risks.

Volume Analysis:
– The 24h trading volume of $15.28 million reflects strong investor interest, supporting further price appreciation.

---

5. Price Predictions and Outlook

Given the recent EVM testnet launch and strategic partnerships, Injective is poised for sustained growth. Analysts project the following price targets:
– Short-Term: $14.16 (Resistance 1)
– Medium-Term: $15.48 (Resistance 2)

However, failure to sustain momentum could see prices retest support levels at $10.07 or lower.

---

6. Risk Analysis

While the outlook for Injective is bullish, traders should consider the following risks:
– Market Volatility: Sudden macroeconomic changes or negative crypto market sentiment could impact INJ prices.
– Overbought Conditions: Momentum indicators, such as RSI and Stochastic Oscillator, suggest the possibility of short-term corrections.
– Resistance at $13.23 (200-Day SMA): A failure to break this level may limit upward momentum.

---

7. Conclusion

Injective Protocol (INJ) has emerged as a leading DeFi platform, bolstered by its EVM testnet launch, growing institutional partnerships, and increased on-chain activity. While technical indicators point to bullish potential, traders should remain cautious of overbought conditions and resistance levels. With its focus on innovation and global adoption, Injective is well-positioned for long-term success in the competitive DeFi landscape.

---

Image source: Shutterstock